Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wenzel

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 29, 2025
Response to Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2- a multinational population-based cohort studyAnna Norberg Hardie, Hans H B Wenzel, Tine H Schnack, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 3, 2023
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide studyKoen De Decker, Hans H B Wenzel, Joost Bart, et al.
International Journal of Clinical Oncology|July 9, 2021
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature reviewEster P Olthof, Maaike A van der Aa, Judit A Adam, et al.
Psycho-Oncology|January 13, 1999
Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trialA C Marcus, K M Garrett, D Cella, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2024
Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mmHans H B Wenzel, Tine H Schnack, Maaike A Van der Aa, et al.
Gynecologic Oncology|January 21, 2026
Impact of COVID-19 on oncological outcomes during follow-up in gynaecological cancer: A nationwide retrospective cohort studyE M Vermaas, H H B Wenzel, M A van der Aa, et al.
Controlled Clinical Trials|February 24, 2001
Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialM A Hasson, R M Fagerstrom, D C Kahane, et al.
Cancers|July 9, 2022
Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort StudyMieke L G Ten Eikelder, Floor Hinten, Anke Smits, et al.
Gynecologic Oncology|November 4, 2025
Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approachesE M Vermaas, P Röling, K M Konior, et al.
Gynecologic Oncology|May 9, 2020
Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?Hans H B Wenzel, Kim G G Van Kol, Hans W Nijman, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|August 29, 2025
Response to Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2- a multinational population-based cohort studyAnna Norberg Hardie, Hans H B Wenzel, Tine H Schnack, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 3, 2023
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide studyKoen De Decker, Hans H B Wenzel, Joost Bart, et al.
International Journal of Clinical Oncology|July 9, 2021
The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature reviewEster P Olthof, Maaike A van der Aa, Judit A Adam, et al.
Psycho-Oncology|January 13, 1999
Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trialA C Marcus, K M Garrett, D Cella, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2024
Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mmHans H B Wenzel, Tine H Schnack, Maaike A Van der Aa, et al.
Gynecologic Oncology|January 21, 2026
Impact of COVID-19 on oncological outcomes during follow-up in gynaecological cancer: A nationwide retrospective cohort studyE M Vermaas, H H B Wenzel, M A van der Aa, et al.
Controlled Clinical Trials|February 24, 2001
Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialM A Hasson, R M Fagerstrom, D C Kahane, et al.
Cancers|July 9, 2022
Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort StudyMieke L G Ten Eikelder, Floor Hinten, Anke Smits, et al.
Gynecologic Oncology|November 4, 2025
Reconsidering follow-up care in gynaecologic oncology: A scoping review exploring alternative approachesE M Vermaas, P Röling, K M Konior, et al.
Gynecologic Oncology|May 9, 2020
Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?Hans H B Wenzel, Kim G G Van Kol, Hans W Nijman, et al.
Pageof 10